Hideo Komita

Immunology and Microbiology · Life Sciences

20h-index1.1kcitations68works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(31), Cancer Immunotherapy and Biomarkers(25), CAR-T cell therapy research(24), Renal and related cancers(20), Immune Cell Function and Interaction(9)

Publications68 total

Supplementary Figure Legend from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S2 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S3 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure Legend from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S2 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Data from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S3 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S3 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Data from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S2 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Table S2 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure S3 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
2023Open Access
Supplementary Figure 3 from CD8<sup>+</sup> T-Cell Responses against Hemoglobin-β Prevent Solid Tumor Growth
2023Open Access
Supplementary Figure 1 from CD8<sup>+</sup> T-Cell Responses against Hemoglobin-β Prevent Solid Tumor Growth
2023Open Access
Supplementary Figure 4 from CD8<sup>+</sup> T-Cell Responses against Hemoglobin-β Prevent Solid Tumor Growth
2023Open Access
Supplementary Figure 5 from CD8<sup>+</sup> T-Cell Responses against Hemoglobin-β Prevent Solid Tumor Growth
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Sadamu Homma(38), Shigeo Koido(34), Toshifumi Ohkusa(26), Hisao Tajiri(26), Kan Uchiyama(21), Jianlin Gong(20), Masato Okamoto(19), Shin Kan(19), Yuko Kamata(17), Shunichi Odahara(16), Masaki Ito(16), Kazuki Takakura(15), Hiroo Imazu(15), Mikio Kajihara(15), Shintaro Tsukinaga(14), Haruo Sugiyama(13), Akitaka Takahara(13), Yoichi Toyama(12), Satoru Yanagisawa(12), Masahiro Ikegami(12)